Towards optimal use of BiTE® antibody constructs nu maximal exploiting the immune system
The usage of bispecific antibodies is a new strategy to combat cancer. The bispecific antibodies, BiTEs in this project, bring the immune cell and the tumor cell together, which leads to an activation of the immune cell. The idea behind this is that the activated immune cell will kill the tumor cell. This technique is already used for hematologic cancer. In this project we will test how BiTE therapy can also be used for solid tumors
The usage of bispecific antibodies is a new strategy to combat cancer. The bispecific antibodies, BiTEs in this project, bring the immune cell and the tumor cell together, which leads to an activation of the immune cell. The idea behind this is that the activated immune cell will kill the tumor cell. This technique is already used for hematologic cancer. In this project we will test how BiTE therapy can also be used for solid tumors.
Other projects
In each PPP project, research institutions, businesses and healthcare organisations work together on a specific health challenge. Browse the full project overview.
Bekijk de programma’s
Binnen onze programma’s werken bedrijven, kennisinstellingen en regionale partners samen aan innovaties die bijdragen aan betere gezondheid en zorg.
Bekijk de partnerschappen
Strategische publiek-private partnerschappen (PPP's) zijn meerjarige samenwerkingen tussen bedrijven, kennisinstellingen en andere partijen.
Hoe kunnen we je helpen?
Heb je een vraag of wil je meer weten over Health Holland? We brengen je graag in contact met de juiste mensen, kennis en mogelijkheden om gezondheidsinnovatie te versnellen.
We have received your message
We will contact you within 3 to 4 working days. If your question is urgent, please contact us directly. Below is the contact option that best matches your subject.
Start again
Something went wrong while sending the form. Please try again.